Anti-TNF Medications Lead To Higher Shingles Risk In RA Patients

One of the most painful and debilitating conditions is shingles.  Find out what a recent study showed…shingles

Nancy Walsh writing in MedPage Today reported, “Patients with rheumatoid arthritis (RA) undergoing treatment with agents such as Enbrel (etanercept), Remicade (infliximab) or Humira (adalimumab) appear to have a significantly increased risk for developing shingles,” according to a study published in the Annals of the Rheumatic Diseases. Researchers found that “the incidence of shingles among patients on anti-tumor necrosis factor (TNF) treatment was 1.6 per 100 patient-years, compared with an incidence of 0.8 per 100 patient-years among those receiving traditional disease-modifying anti-rheumatic drugs (DMARDs).”

Comment: What can I say?  These are worrisome findings and indicate that people with RA on biologics should be vaccinated.

For more information on arthritis treatments and other arthritis problems,  go to:

Arthritis Treatment

And don’t forget to sign up for  free weekly arthritis tips and a free copy of our special report “The Consumer’s Guide to Arthritis”

Just go here Contact